Whether you're managing Type 2 diabetes or pursuing sustainable weight loss, we offer convenient online weight loss and diabetes prescriptions with flexible, affordable options to fit your needs
ProRx LLC in Exton, PA, is the most heavily sanctioned partner, with two FDA Warning Letters (March 2025 and April 2026), two voluntary sterile-product recalls covering compounded tirzepatide and semaglutide in August 2024 and October 2025, an open FDA 483 from September/October 2025, and an explicit FDA warning of possible seizure or injunction
Unimolecular dual incretins maximize metabolic benefits in rodents, monkeys, and humans
The local GLP-1 system in the olfactory bulb is required for odor-evoked cephalic phase of insulin release in mice
Comment on impact of GLP-1 agonists and SGLT-2 inhibitors on diabetic retinopathy progression: an aggregated electronic health record study